Skip to content

Research on the Mechanism of Adhesion and Recurrence after Strabismus Surgery

Research on the Mechanism of Adhesion and Recurrence after Strabismus Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123513
Enrollment
Unknown
Registered
2026-04-27
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Strabismus

Interventions

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.The age range is from 5 to 50 years old, with no gender restrictions, and all applicants must be in good health. 2. Patients diagnosed with strabismus by ophthalmology professionals, with corrected vision not lower than 0.8, and the difference in the best corrected vision between the two eyes not exceeding 2 lines. 3. Wear/Do not wear corrective glasses for at least 3 months, with the lens power being the latest optometry prescription. 4. Simple strabismus, excluding thyroid-associated ophthalmopathy (TAO), orbital fractures, and previous history of ocular trauma, etc., which are diseases inherently characterized by inflammation/fibrosis; 5. No history of neurological or mental disorders such as intellectual disability, language expression disorder, or attention disorder that may affect the cooperation in the experiment; 6.The patient himself and his guardian have given informed consent, voluntarily participated in the experiment and signed the informed consent form. They are able to follow the experimental protocol and complete the follow-up.

Exclusion criteria

Exclusion criteria: 1. Craniofacial deformities involving the orbit; 2. Patients who have undergone surgery on the vertical and rotational muscles; 3. Patients with restricted or paralyzed eyes due to restrictive or paralytic strabismus; 4. Patients with severe neurological impairments, such as those with cerebral palsy; 5. Patients with mild language/learning disabilities who meet the surgical criteria;

Design outcomes

Primary

MeasureTime frame
Expression levels of key fibrosis genes and proteins (Piezo1/YAP/a-SMA);

Countries

China

Contacts

Public ContactZhang Fang

Eye Hospital, Wenzhou Medical University

zf@mail.eye.ac.cn+86 577 88068816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026